Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Case Report

Volume 7, Number 12, December 2015, pages 998-1001

Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan

Figures

Figure 1.
Figure 1. Patient’s initial chest X-rays.
Figure 2.
Figure 2. Patient’s thoracic angiotomography.
Figure 3.
Figure 3. Following thoracic X-rays showing signs of pulmonary edema.

Table

Table 1. Patient’s Hemodynamic Monitoring
 
MonitoringSAPDAPMAPHRCOICISCVPPWPPASPPADPPAMPSVRIPVRI
SAP: systolic arterial pressure; DAP: diastolic arterial pressure; MAP: mean arterial pressure; HR: heart rate; CO: cardiac output; CI: cardiac index; SI: systolic index; CVP: central venous pressure; PWP: pulmonary wedge pressure; PASP: pulmonary artery systolic pressure; PADP: pulmonary artery diastolic pressure; PAMP: pulmonary artery mean pressure; SVRI: systemic vascular resistance index; PVRI: pulmonary vascular resistance index.
Initial131901041184.73.025.214204332362,411.5421.3
4 h after levosimendan121891001115.33.430.212153622272,090.8278.2
Post-infusion10569811065.83.734.68102412161,590.9130.8